Kenvue (MEX:KVUE) Short Interest


MEX:KVUE Kenvue Inc MEX:KVUE
47 GF Score
Price MXN331.00
GF Value MXN352.46
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Kenvue Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

MEX:KVUE vs KMB, EL, CHD: Short Interest Comparison

For the Household & Personal Products subindustry, Kenvue's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kenvue Short Interest vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Kenvue's Short Interest distribution charts can be found below:

* The bar in red indicates where Kenvue's Short Interest falls into.


MEX:KVUE
47GF Score
Kenvue Inc MEX:KVUE
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Kenvue (MEX:KVUE) Overvalued in 2026?

Based on GuruFocus' analysis, Kenvue stock appears to be undervalued. The current stock price of MXN331.00 is trading 6.1% below its estimated GF Value™ of MXN352.46. GuruFocus considers Kenvue to be Fairly Valued.

Key valuation signals for MEX:KVUE:

  • Short Interest:
  • GF Value™: MXN352.46 vs. price of MXN331.00 (6.1% below fair value)
  • GF Score™: 47/100 with 6 warning signs

No single metric tells the full story. See the MEX:KVUE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kenvue Business Description

Address 1 Kenvue Way, Summit, NJ, USA, 07901
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
47GF Score

Get the complete analysis for MEX:KVUE

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN331.00
Price
MXN352.46
GF Value